Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called ‘protein degraders’ which can be deployed to combat what have previously been regarded as ‘undruggable’ diseases, including cancers and neurodegenerative diseases.
Draft 340B reforms include user fees, clarity around contract pharmacies
Six bipartisan senators suggested several changes to improve the “stability and transparency” of the 340B drug discount program in a long-awaited draft bill released Friday.
February 3, 2024